
The company reported selling its remaining Oncosem shares on Borsa Istanbul, recording a gain and ending its investment in the company.
Bulls Girişim Sermayesi Yatırım Ortaklığı reported that it sold 280,000 shares in Oncosem Onkolojik Sistemler on October 9, ending its investment in the company. The shares were sold through Borsa Istanbul’s Equity Market.
The KAP disclosure lists a total transaction amount of 29,683,513 and a price of 106 per share. Bulls GSYO reported a gain of 26,869,442.65 from the sale.
The sale transfers Bulls GSYO’s existing shares to market buyers; it does not provide new capital to Oncosem. Bulls GSYO said the sale’s effect on its operations was positive, but did not state how it would use the proceeds.
This article was produced with the help of AI technology. Source: Yahoo Finance